Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering.
The medical devices industry observes a significant milestone with the publication of an in-depth analysis focusing on the transdermal drug delivery pipeline. This report provides a panoramic view of the ongoing developments in transdermal drug delivery systems, a field that enables medication to be delivered through the skin directly into the bloodstream.
Transdermal delivery devices, typically medicated patches, are gaining prominence due to their non-invasive nature and sustained drug release capabilities. The detailed report includes a global overview of various products under development, from early-phase innovations to approved market entrants.
Highlighting the attention to detail encompassed within the report, the document provides a thorough product breakdown including descriptions, strategic collaborations, and additional relevant activities. It spotlights key clinical trial data and ongoing trials pertinent to pipeline offerings. Furthermore, the report reviews active players in the segment and enumerates their pipeline projects.
The analysis extends to cover an array of development stages and offers crucial insights into the regulatory pathway challenges and triumphs faced within the transdermal drug delivery sector. The geographical scope of the report examines the innovative efforts across various regions and countries, offering a global perspective on the transdermal drug delivery arena.
Key Developments and Strategic Directions
- Extensive categorization of pipeline products based on stages of development
- Detailed profiles of prominent companies and their pipeline strategies
- Assessment of emerging market players with potentially disruptive portfolios
- Insight into significant clinical trial data and its implications for ongoing product development
With the publication of this report, industry stakeholders are afforded critical insights to enhance R&D strategies, identify market opportunities, and understand the competitive landscape. It equips professionals with the knowledge to devise robust market entry and expansion strategies and to foresee potential mergers and acquisitions, leveraging the comprehensive analysis of promising pipeline products.
Industry players looking to stay ahead of the curve will find the report invaluable for its in-depth analysis of the products' current stages of development, geographic reach, and projected launch timelines.
The transdermal drug delivery segment is rapidly evolving, and this report serves as a key resource for those seeking to navigate its complexities and capitalize on the opportunities presented within this innovative sector of medical devices.
A selection of companies mentioned in this report includes:
- 3P Biotechnologies Inc
- 4P Therapeutics LLC
- Abionic SA
- Actuated Medical Inc
- Adynxx Inc
- Aequus Pharmaceuticals Inc
- AerMedX Ltd
- Agile Therapeutics Inc
- Allergan Ltd
- American Chemical Society
- AMW GmbH
- Amzell BV
- Apogee Technology Inc
- Asahi Kasei Pharma Corp
- ASCIL Biopharm
- Avecho Biotechnology Ltd
- Avro Life Sciences
- BioNxt Solutions Inc.
- Boryung Pharmaceutical Co Ltd
- Burke Pharmaceuticals LLC
- Candesant Biomedical Inc
- Carnegie Mellon University
- Cassava Sciences Inc
- CB Scientific Inc
- Cerimon Pharmaceuticals, Inc. (Inactive)
- Chrono Therapeutics Inc
- Cipla Ltd
- Clexio Biosciences Ltd
- Corium Inc
- Daewon Pharmaceutical Co Ltd
- Daewoong Pharmaceutical Co Ltd
- DBV Technologies SA
- DD Therapeutics LLC (Inactive)
- Delpor Inc
- Dermisonics Inc
- Dharma Therapeutics, Inc. (Inactive)
- Diomics Corp
- Dong-A ST Co Ltd
- Drexel University
- DURECT Corp
- Echo Therapeutics Inc
- Emplicure AB
- Endo International Plc
- Endomimetics LLC
- Extend Biosciences Inc
- Fe3 Medical Inc
- Futura Medical Plc
- Georgetown University
- Georgia Institute of Technology
- Georgia State University
- GlobeStar Therapeutics Corp
- Henley Ion LLC
- Hera Health Solutions
- Hisamitsu Pharmaceutical Co Inc
- I M Sechenov Moscow State Medical University
- Icure Pharmaceutical Inc
- ImmunoMatrix LLC
- ImmuPatch
- Indian Institute of Science
- Indian Institute of Technology Bombay
- Indian Institute of Technology Hyderabad
- InMed Pharmaceuticals Inc
- Institute of Materials Research & Engineering
- Intercell AG (Inactive)
- Interstitial NS
- Isis Biopolymer Inc (Inactive)
- James J. Peters VA Medical Center
- Janisys
- Jiaxing Xinwen Biotechnology Co Ltd
- Jubilee Biotech
- Karolinska Institute
- Kindeva Drug Delivery LP
- KTH Royal Institute of Technology
- Leo Pharma AS
- Livzon Pharmaceutical Group Co Ltd
- Lohmann Therapie-Systeme AG
- Luye Pharma Group Ltd
- Magnetar Medical Devices Ltd
- Massachusetts Institute of Technology
- Mayne Pharma Group Ltd
- Medherant Ltd
- MEDRx Co Ltd
- MedRx, Inc.
- Microdermics Inc
- Micron Biomedical Inc
- Micropoint Technologies Pte Ltd
- Mineed Technology Co Ltd
- Mycrodose Therapeutics Inc
- MyLife Technologies
- Nanyang Technological University
- National Dental Centre Singapore
- National University of Singapore
- Nemaura Pharma Ltd
- NeuroDerm Ltd
- Nexgel Inc
- Nitto Denko Corp
- North Carolina State University
- Nova Graphene Ballistics Inc
- Noven Pharmaceuticals Inc
- NutriBand Inc
- Nuvo Pharmaceuticals Inc
- Ohio State University
- Osprey Medical Inc
- Pantec Biosolutions AG
- PassPort Technologies Inc
- Pebble Inc
- PharmaTher Holdings Ltd
- Privo Technologies Inc
- Prometheon Pharma LLC
- Purdue University
- Quadmedicine
- Quoin Pharmaceuticals Inc
- Radius Health Inc
- Rescue Biomedical LLC
- Ryah Medtech Inc
- Samyang Biopharmaceuticals Corp
- Sanofi
- Satio Inc
- Seelos Therapeutics, Inc.
- Shenox Pharmaceuticals LLC
- Sichuan Kelun Pharmaceutical Co Ltd
- Sinsin Pharmaceutical Co Ltd
- SK Chemicals Co Ltd
- Skinject Inc
- Sorrento Therapeutics Inc
- Sparsha Pharma International Pvt Ltd
- Sree Chitra Tirunal Institute for Medical Sciences & Technology
- Stanford University
- Starton Therapeutics Inc
- Suzhou Reveda Medical Co Ltd
- Swansea University
- Syntropharma Ltd
- Taho Pharmaceuticals Ltd
- Teikoku Pharma USA Inc
- tesa Labtec GmbH
- Teva Pharmaceutical Industries Ltd
- Texas Tech University
- The Sheikh Zayed Institute for Pediatric Surgical Innovation
- TheraJect Inc
- Therapeutic Systems Research Laboratories Inc
- TheraSolve NV (Inactive)
- Theratech, Inc.
- Theris Medical Inc
- Thrudermic LLC
- Titan Pharmaceuticals Inc
- Transcu Group Limited (Inactive)
- Transdermal Delivery Solutions Corp
- Transdermal Specialties Inc
- TransPharma Medical Ltd (Inactive)
- Transport Pharmaceuticals Inc
- University of Connecticut Health Center
- University of Helsinki
- University of Hong Kong
- University of Illinois at Chicago
- University of Iowa
- University of South Florida
- University of the Philippines Manila
- University of the Witwatersrand
- University of Tokyo
- University of Toronto
- University of Washington
- Vaxess Technologies Inc
- Vaxxas Pty Ltd
- Verndari Inc
- ViiV Healthcare UK Ltd
- Virpax Pharmaceuticals Inc
- Vyteris, Inc. (Inactive)
- Wellfully Ltd
- Xel Pharmaceuticals Inc
- Zambon Italia Srl
- Z-Cube Srl
- Zosano Pharma Corp
- Zylo Therapeutics LLC
- Zynerba Pharmaceuticals Inc
For more information about this report visit https://www.researchandmarkets.com/r/li6mwh
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
